Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Anesteziol Reanimatol ; 61: 224-227, 2017 Sep.
Artigo em Russo | MEDLINE | ID: mdl-29465209

RESUMO

Despite the use of modern methods of prevention, at least 10% of patients operated on for ophthalmic indications not develop corneal erosion as the indirect complication of general anesthesia. OBJECTIVE: To reduce the number of ophthalmic complications of general anesthesia by prophylactic use of new mito- chondria-targeted antioxidants - Vizomitin (eye drops). MATERIALS AND METHODS: 70 patients, which was supposed to perform the average duration of operations under general anesthesia were randomized into 3 groups depending on the method specific (pharmacological) prevention of corneal erosions: (1) control (specic (pharmacological) prevention was not carried out), (2), using preparation "natural tear, and (3) "Vizomitin" preparation. Postoperative biomicroscopy was performed to assess the condition of the cornea, tear film stability was measured and the height of the tear meniscus. RESULTS: When using eye drops "Vizomitin" value is an indicator of stability of the tear film on the 3rd day after the operation more than in the control group of patients by 51% (p = 0.012) and patients groups, natural tear by 57% (p = 0.013). Surgical interventions performed under general anesthesia, leading to an increase in the number ofpatients with decreased tear meniscus height index of the control group with 4 to 7 patients (p = 0.30) in the group of natural tear from 3 to 11 patients (p = 0.008) . In the group with drug "Vizomitin" the number of such patients is reduced from 7 to 1 (p = 0.018). CONCLUSION: In the surgical procedures under general anesthesia eye drops "Vizomitin" effectively prevents the devel- opment of corneal erosion.


Assuntos
Anestesia Geral/efeitos adversos , Antioxidantes/uso terapêutico , Compostos de Benzalcônio/uso terapêutico , Córnea/efeitos dos fármacos , Síndromes do Olho Seco/prevenção & controle , Metilcelulose/uso terapêutico , Mitocôndrias/efeitos dos fármacos , Plastoquinona/uso terapêutico , Adulto , Antioxidantes/administração & dosagem , Compostos de Benzalcônio/administração & dosagem , Córnea/patologia , Combinação de Medicamentos , Síndromes do Olho Seco/etiologia , Humanos , Lubrificantes Oftálmicos/administração & dosagem , Lubrificantes Oftálmicos/uso terapêutico , Metilcelulose/administração & dosagem , Pessoa de Meia-Idade , Mitocôndrias/patologia , Plastoquinona/administração & dosagem , Complicações Pós-Operatórias , Resultado do Tratamento , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...